Further Studies on the Mechanism of Action of Human Plasma in Stimulating Prostacyclin Production by Rat Smooth Muscle Cells

Summary

Human normal plasma stimulates prostacyclin (PGI₂) production by vascular cells. This plasma activity may be greatly modified in different pathological conditions. The purpose of this study was to characterize some aspects of the mechanism of action of plasma in modulating PGI₂ release. Cultured rat aortic smooth muscle cells were used. Citrated plasma from healthy donors stimulated PGI₂ production in a concentration-dependent way. Plasma-derived serum containing increasing concentrations of platelets had the same PGI₂ stimulating activity as citrated plasma. Plasma stimulation of PGI₂ production was accompanied by release of endogenously incorporated arachidonic acid (AA) from the cell membrane. Similarly to AA, plasma induced PGI₂ synthesis only once, a second or third challenge producing a reduced response from the cells. Cells stimulated twice with plasma responded to AA like unstimulated cells while cells stimulated twice with AA were poorly responsive to subsequent stimulation with plasma. When the cells were repeatedly stimulated with AA in the presence of plasma no refractoriness was apparent.

This study suggests that plasma increases PGI₂ synthesis by the release of endogenous substrate from the cell membrane and by protecting the cells from self-inactivation during AA conversion to prostaglandins.

Keywords

Prostacyclin - Plasma factor - Vascular smooth muscle cells

• References

• 1 Remuzzi G, Marchesi D, Livio M, Schieppati A, Mecca G, Donati MB, de Gaetano G. Prostaglandins, plasma factors and hemostasis in uremia. In: Hemostasis, Prostaglandins and Renal Disease. Remuzzi G, Mecca G, de Gaetano G. (eds) Raven Press; New York: 1980. pp 273-281
• 2 Mac Intyre DE, Pearson JD, Gordon JL. Localization and stimulation of prostacyclin production in vascular cells. Nature 1978; 271: 549-551
• 3 Defreyn G, Vergara-Dauden M, Machin SJ, Vermylen J. A plasma factor in uremia which stimulates prostacyclin release from cultured endothelial cells. Thromb Res 1980; 19: 695-699
• 4 Remuzzi G, Livio M, Cavenaghi AE, Marchesi D, Mecca G, Donati MB, de Gaetano G. Unbalanced prostaglandin synthesis and plasma factor in uremic bleeding. A hypothesis Thromb Res 1978; 13: 531-536
• 5 Remuzzi G, Misiani R, Marchesi D, Livio M, Mecca G, de Gaetano G, Donati MB. Haemolytic-uraemic syndrome. Deficiency of plasma factor(s) regulating prostacyclin activity Lancet 1978; 2: 871-872
• 6 Remuzzi G, Misiani R, Mecca G, de Gaetano G, Donati MB. Thrombotic thrombocytopenic purpura. A deficiency of plasma factors regulating platelet-vessel-wall interaction N Engl J Med 1978; 299: 311
• 7 Carreras LO, Vermylen JG. “Lupus” anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation Thromb Haemos- tas 1982; 48: 38-40
• 8 Kant KS, Dosekun AK, Chandran KG P, Glas-Greenwalt P, weiss MA, Pollak VE. Deficiency of a plasma factor stimulating vascular prostacyclin generation in patients with lupus nephritis and glomerular thrombi and its correction by ancrod in vivo and in vitro observations. Thromb Res 1982; 27: 651-658
• 9 De Castellarnau C, Vila L, Sancho MJ, Borrel M, Fontcuberta J, Rutllant ML. Lupus anticoagulant, recurrent abortion and prostacyclin production by cultured smooth muscle cells. Lancet 1983; 2: 1137-1138
• 10 Zoja C, Arnout J, Deckmyn H, Vermylen J. Partial purification and characterization of the prostacyclin stimulating plasma factor. Thromb Haemostas 1983; 50: 240 (Abstr.)
• 11 Travo P, Barret G, Burnostock G. Differences in proliferation of vascular primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels 1980; 17: 110-116
• 12 Vicenzi E, Biondi A, Rambaldi A, Donati MB, Mantovani A. Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. Clin Exp Immunol 1984; 57: 385-392
• 13 Chiabrando C, Noseda A, Castagnoli MN, Romano M, Fanelli R. Quantitative profiling of prostaglandins and thromboxane by high resolution gas chromatography-selected-ion monotoring. J Chromatogr 1983; 279: 581-586
• 14 Patrono C, Pugliese F, Ciabattoni G, Patrignani P, Maseri A, Chierchia S, Peskar BA, Cinotti GA, Simonetti BM, Petrucci A. Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest 1982; 69: 231-239
• 15 Ritter JM, Ongari MA, Ochard MA, Lewis PJ. Prostacyclin synthesis is stimulated by a serum factor formed during coagulation. Thromb Haemostas 1983; 49: 58-60
• 16 Ritter JM, Ochard MA, Lewis PJ. Stimulation of vascular prostacyclin production by human serum. Biochem Pharmacol 1982; 31: 3047-3050
• 17 Tremoli E, Jaffe EA, Hefton JM, Tack-Goldman K, weksler BB. PGI₂production by endothelial cells: effects of whole blood and plasma derived sera from normal and hyperlipidemic subjects. Thromb Haemostas 1983; 50: 98 (Abstr.)
• 18 Coughlin SR, Moskowitz MA, Antoniades HN, Levine L. Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet-derived growth factor. Proc Nat Acad Sci USA 1981; 78: 7134-7138
• 19 Irvine RF. How is the level of free arachidonic acid controlled in mammalian cells. Biochem J 1982; 204: 3-16
• 20 Dejana E, Balconi G, de Castellarnau C, Barbieri B, Vergara-Dauden M, de Gaetano G. Prostacyclin production by human endothelial and bovine smooth muscle cells in culture. Effect of repeated stimulation with arachidonic acid, thrombin and ionophore A23187 Biochim Biophys Acta 1983; 750: 261-267
• 21 Adams Brotherton AF, Hoak JC. Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase. J Clin Invest 1983; 72: 1255-1261
• 22 Egan RW, Gale PH, Baptista EM, Kennicott KL, VandenHeuvel wJ, walker RW, Fargeness PE, Kuehl FA. Oxidation reactions by prostaglandin cycloxygenase-hydroperoxidase. J Biol Chem 1981; 256: 7352-7361
• 23 Todisco A, Deckmyn H, D’Hondt L, Zoja C, Vermylen J. The prostacyclin stimulating plasma factor (PSPF) protects endothelial cells from exhaustion. Thromb Haemostas 1983; 50: 242 (Abstr.)
• 24 Dormandy TL. Free radicals oxidation and antioxidant. Lancet 1978; 1: 647-650
• 25 Ritter JM, Ochard MA, Lewis PJ. Inhibition of vascular epopros- tenol (prostacyclin, PGI₂) production in vitro by plasma from healthy subjects and patients with severe renal impairment. Br J Clin Pharmacol 1982; 14: 379-383
• 26 Chandrabose KA, Bonser RW, Cuatrecasas P. Role of extracellular arachidonate in regulation of prostaglandin biosynthesis in cultured 3T3 fibroblasts. Adv Prostaglandin Thromboxane Res 1980; 6: 249-253